Oramed Investor Suit Seeks To Claw Back Stock Awards
An Oramed Pharmaceuticals stockholder filed a proposed class action Wednesday in Delaware's Chancery Court seeking to recover more than 1.3 million shares she claims the company's board of directors improperly awarded...To view the full article, register now.
Already a subscriber? Click here to view full article